Funded Startups in Daejeon
Daejeon’s most recent rounds shown here include one clear size outlier: Raion Robotics’ $17M Series A (2025-09-20), which sits far above the other disclose…
Daejeon’s most recent rounds shown here include one clear size outlier: Raion Robotics’ $17M Series A (2025-09-20), which sits far above the other disclosed amounts in the list (the next-largest disclosed round is TR’s $2M on 2025-10-31). Most entries cluster tightly by time: six of the seven rows fall between 2025-09-09 and 2025-11-11, spanning about two months of late 2025 activity.
Stage and disclosure patterns also concentrate. Of the seven rows, five carry a Seed or Series A label (Raion Robotics: Series A $17M; TR: Series A $2M; Dream Appeal: Series A $1M; GigaEte: Seed $650K; Lysin Bio: Seed undisclosed), while two are marked “undisclosed” and one is “Venture - Series Unknown” (VPIX Medical, 2025-11-02). Sector coverage is led by healthcare-adjacent categories: three entries explicitly include healthcare/biopharma in their listed focus (Lysin Bio; VPIX Medical; TR), alongside additional education (Dream Appeal) and robotics (Raion Robotics) within the same Daejeon geography. The newest row is Dream Appeal on 2025-11-28; the oldest is Nanosystem on 2025-09-09.
Most recent rounds
7 shownRelated listings
Frequently asked
Which company has the largest disclosed round in the Daejeon list, and how does it compare to the rest?
Raion Robotics’ $17M Series A on 2025-09-20 is the only disclosed amount well above the others. The remaining disclosed rounds are $2M (TR, 2025-10-31), $1M (Dream Appeal, 2025-11-28), and $650K (GigaEte, 2025-09-10), with multiple rows marked undisclosed.
Do the recent rounds cluster into a narrow time window, or are they spread out?
They cluster. Six of seven rounds fall between 2025-09-09 and 2025-11-11 (Nanosystem 2025-09-09 through Lysin Bio 2025-11-11), with only Dream Appeal (2025-11-28) extending beyond that core window.
How much of the disclosed picture is missing due to undisclosed or unknown round types?
Two of seven rows list “undisclosed” amounts (Lysin Bio on 2025-11-11 and Nanosystem on 2025-09-09), and one row uses a “Venture - Series Unknown” label (VPIX Medical on 2025-11-02) with an undisclosed amount. The result is a partially comparable set: only four rows show disclosed amounts ($1M, $2M, $17M, $650K).
Are any sectors over-represented in these Daejeon entries?
Healthcare/biopharma appears most frequently. Three entries explicitly include healthcare in the category field—Lysin Bio (biotechnology/pharmaceuticals/healthcare, 2025-11-11), VPIX Medical (healthcare, 2025-11-02), and TR (healthcare, 2025-10-31)—while the other listed focuses split across education (Dream Appeal), robotics (Raion Robotics), and uncategorized “—” for GigaEte and Nanosystem.
Is there a stage pattern worth noting for deal mix across the dates shown?
Seed and Series A dominate the labeled stages among the seven rows. Seed appears for GigaEte ($650K on 2025-09-10) and Lysin Bio (undisclosed on 2025-11-11), while Series A appears for Raion Robotics ($17M on 2025-09-20), TR ($2M on 2025-10-31), and Dream Appeal ($1M on 2025-11-28), with the remaining two entries not fitting those labels (VPIX Medical: “Venture - Series Unknown,” plus the two undisclosed Seed and Seed-labeled rows).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.